Contemporary risk factors that cause disseminated lung diseases

View or download the full article: 
PDF icon health-risk-analysis-2020-4-20.pdf
UDC: 
616.24-002
DOI: 
10.21668/health.risk/2020.4.20.eng
Authors: 

E.A. Borodulina, E.V. Yakovleva

Organization: 

Samara State Medical University, 89 Chapaevskaya Str., Samara, 443099, Russian Federation

Abstract: 

As per data provided by Rosstat, in 2018 primary morbidity with respiratory diseases amounted to 35,982 per 100 thousand people; respiratory diseases account for more than 25% in the structure of overall population morbidity and they to a great extent depend on risk factors occurrence. Disseminated lung diseases are combined into one specific group among respiratory diseases as per x-ray evidence.
Our research goal was to review contemporary risk factors that cause disseminated lung diseases in order to apply them in diagnostics. We searched for scientific works that were relevant for our research in such databases as RSCI, CyberLeninka, Scopus, Web of Science, MedLine, and PubMed.
There are a lot of classifications for disseminated lung diseases based on morphologic substrate peculiarities, etiology and other signs; it proves the issue is truly complicated. Patients with disseminated damage to lungs have similar x-ray picture of the disease and results obtained via general clinical tests also have no pathognomonic peculiarities. Clinical experts usually divide disseminations into those with infectious genesis (tuberculosis, HIV-associated disseminations, and fungus diseases) and those with non-infectious genesis (tumor disseminations, interstitial lung diseases, lysosomal storage disorders, etc.). The review outlines factors that influence both occurrence and development of lung diseases accompanied with dissemination syndrome. The greatest attention is paid to socially significant diseases as risk factors that cause them can be detected by a doctor in a patient’s case history and applied for differential diagnostics. It is necessary to develop relevant prevention activities aimed at reducing risks of disseminated lung diseases as they will allow preventing morbidity and mortality among patients suffering from lung disseminations caused by correctable risk factors.

Keywords: 
lung dissemination syndrome, risk factors, interstitial lung diseases, tuberculosis, pneumonia, HIV-infection, bronchiole-alveolar cancer, amyloidosis, pneumoconiosis
Borodulina E.A., Yakovleva E.V. Contemporary risk factors that cause disseminated lung diseases. Health Risk Analysis, 2020, no. 4, pp. 181–187. DOI: 10.21668/health.risk/2020.4.20.eng
References: 
  1. Sazonova O.V., Isakova O.N., Sukhacheva I.F., Komarova M.V. Habitat and incidence of respiratory organs diseases in the Samara population. Gigiena i sanitariya, 2014, vol. 93, no. 4, pp. 33–36 (in Russian).
  2. Wallis A., Spinks K. The diagnosis and management of interstitial lung diseases. BMJ, 2015, vol. 7, pp. 70–72. DOI: 10.1136/bmj.h2072
  3. Il'kovich M.M., Novikova L.N., Il'kovich Yu.M. Discrepancies in Understanding Interstitial Lung Disease. Doctor.Ru, 2013, no. 8 (86), pp. 41–45 (in Russian).
  4. Yankovskaya A.E., Gorbunov I.V., Chernogoryuk G.E. Vliyanie sposoba vychisleniya vesovykh koeffitsientov priznakov i postroeniya bezizbytochnykh bezuslovnykh diagnosticheskikh testov dlya gibridnoi intellektual'noi sistemy differentsial'noi diagnostiki disseminirovannykh zabolevanii legkikh [Influence exerted by a procedure applied to calculate weighted coefficient of signs and building up irredundant unconditioned diagnostic tests for hybrid and intellectual system used for differential diagnostics of disseminated lung diseases]. VII Vserossiiskaya nauchno-prakticheskaya konferentsiya «Nechetkie sistemy, myagkie vychisleniya i intellektual'nye tekhnologii». Sankt-Peterburg, 2017, vol. 2, pp. 191–200 (in Russian).
  5. Zagdyn Z.M. The main risk factors and their impact on the HIV/tuberculosis epidemic. Rossiiskii mediko-biologicheskii vestnik imeni akademika I.P. Pavlova, 2019, vol. 27, no. 2, pp. 137–149 (in Russian).
  6. Straetemans M., Bierrenbach A.L., Nagelkerke N., Glaziou P., van der Werf M.J. The effect of tuberculosis on mortality in HIV-positive people: meta-analysis. PLoS One, 2010, vol. 30, no. 5 (12), pp. 45–47. DOI: 10.1371/journal.pone.001524
  7. Borodulina E., Vdoushkina E., In'kova A. Tuberculosis and HIV-infection. Vrach, 2020, vol. 31, no. 1, pp. 37–43 (in Russian).
  8. Mishin V.Yu., Ergeshov A.E., Mishina A.V. Diagnosis and differential diagnosis of disseminated lung lesions in patients with HIV infection (review). Consilium Medicum, 2018, vol. 20, no. 3, pp. 8–13 (in Russian).
  9. Cardona P.J. Pathogenesis of tuberculosis and other mycobacteriosis. Enferm Infec Microbiol Clin, 2018, vol. 36, no. 1, pp. 38–46. DOI: 10.1016/j.eimc.2017.10.015
  10. Amansakhedov R.B., Limarova I.V., Perfil'ev A.V., Abdullaev R.Yu., Sigaev A.T., Ergeshov A.E. Comparative analysis of the semiotics of disseminated pulmonary tuberculosis and exogenous allergic alveolitis in accordance with the data of computed tomography. Vestnik rentgenologii i radiologii, 2016, vol. 97, no. 2, pp. 79–84 (in Russian).
  11. Kornilov M.S., Yakovlev A.A., Pozdeeva E.S., Zhdanova S.N. Risk factors that contribute to the formation of combined forms of tuberculosis and HIV infection in Primorsky krai. Tikhookeanskii meditsinskii zhurnal, 2018, no. 3 (73), pp. 87–91 (in Russian).
  12. Eremenko E.P., Borodulina E.A., Amosova E.A. VICh-infektsiya u detei kak factor riska tuberkuleza [HIV-infection in children as a tuberculosis risk factor]. Tuberkulez i bolezni legkikh, 2017, vol. 95, no. 1, pp. 18–21 (in Russian).
  13. Aguilar J.P., Arriaga M.B., Rodas M.N., Martins E. Netto Smoking and pulmonary tuberculosis treatment failure: a case-control study. J Bras Pneumol, 2019, vol. 25, no. 45 (2), pp. 28–31. DOI: 10.1590/1806-3713/e20180359
  14. Patra J., Jha P., Rehm J., Suraweera W. Tobacco smoking, alcohol drinking, diabetes, low body mass index and the risk of self-reported symptoms of active tuberculosis: individual participant data (IPD) meta-analyses of 72,684 individuals in 14 high tuberculosis burden countries. PLoS One, 2014, vol. 2, no. 9 (5), pp. 78–83. DOI: 10.1371/journal.pone.0096433
  15. Borovitskii V.S. Pneumocystic pneumonia. Etiology, pathogenesis, clinic, differential diagnostics, treatment (lecture). Problemy meditsinskoi mikologii, 2012, vol. 14, no. 1, pp. 13–20 (in Russian).
  16. Ermak T.N., Kravchenko A.V. Razvitie pnevmotsistoza i toksoplazmoza u bol'nykh VICh-infektsiei pri otsutstvii vyrazhennogo immunodefitsita [Pneumocystosis and toxoplasmosis occurrence in patients with HIV-infection in case there is no apparent immune deficiency]. Zhurnal infektologii, 2019, vol. 11, no. 3, pp. 30–34 (in Russian).
  17. Huang Y.S., Yang J.J., Lee N.Y., Chen G.J., Ko W.C., Sun H.Y., Hung C.C. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review. Expert Rev Anti Infect Ther, 2017, vol. 15, no. 9, pp. 873–892. DOI: 10.1080/14787210.2017.1364991
  18. Zimina V.N., Astaf'ev A.V. Community-acquired pneumonia in adult HIV-infected patients: course, treatment, and prevention. Pul'monologiya, 2016, vol. 26, no. 4, pp. 488–497 (in Russian).
  19. Bozoyan A.A., Puzyreva L.V. Features of bacterial pneumonia at HIV-positive people. Krymskii terapevticheskii zhurnal, 2019, no. 2, pp. 28–32 (in Russian).
  20. Cui Z., Lin M., Nie S., Lan R. Risk factors associated with Tuberculosis among people living with HIV/AIDS: A pair-matched case-control study in Guangxi, China. PLoS One, 2017, vol. 12, no. 3, pp. 36–39. DOI: 10.1371/journal.pone.0173976
  21. Silva D.R., Muñoz-Torrico M., Duarte R., Galvão T., Bonini E.H., Arbex F.F., Arbex M.A., Augusto V.M., Rabahi M.F., Mello F.C. Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs. J Bras Pneumol, 2018, vol. 44, no. 2, pp. 145–152. DOI: 10.1590/s1806-37562017000000443
  22. Urazovskii N.Yu., Aver'yanov A.V., Lesnyak V.N. Problems of differential diagnosis of bronchioloalveolar carcinoma. Klinicheskaya praktika, 2013, no. 3 (15), pp. 61–72 (in Russian).
  23. Boffetta P., Jayaprakash V., Yang P., Asomaning K., Muscat J.E., Schwartz A.G., Zhang Z.F., Le Marchand L. [et al.]. Tobacco smoking as a risk factor of bronchioloalveolar carcinoma of the lung: pooled analysis of seven case-control studies in the International Lung Cancer Consortium (ILCCO). Cancer Causes Control, 2011, vol. 22, no. 1, pp. 73–79. DOI: 10.1007/s10552-010-9676-5
  24. Nomori H., Mori T., Iyama K., Okamoto T., Kamakura M. Risk of bronchioloalveolarcarcinoma in patients with humanT-cell lymphotropicvirus type 1 (HTLV-I): case-control study results. Ann Thorac Cardiovasc Surg, 2011, vol. 17, no. 1, pp. 19–23. DOI: 10.5761/atcs.oa.09.01529
  25. O’Leary S.M., Coleman M.M., Chew W.M. Cigarette smoking impairs human pulmonary immunity to mycobacterium tuberculosis. Amer. J. Respir. Crit Care Med, 2014, vol. 190, no. 12, pp. 1430–1436. DOI: 10.1164/rccm.201407–1385OC
  26. Kosarev V., Babanov S. Exogenous allergic alveolitis. Vrach, 2013, no. 2, pp. 2–6 (in Russian).
  27. Cormier Y. Hypersensitivity pneumonitis (extrinsic allergic alveolitis): Canadian historical perspective. Can Respir J, 2014, vol. 21, no. 5, pp. 277–286. DOI: 10.1155/2014/128940
  28. Babanov S.A., Budash D.S. Occupational lung diseases: statistical indicators, risk assessment and biological markers. Meditsina neotlozhnykh sostoyanii, 2018, no. 1 (88), pp. 142–150 (in Russian).
  29. Shi P., Xing X., Xi S., Jing H., Yuan J., Fu Z., Zhao H. Trends in global, regional and national incidence of pneumoconiosis caused by different aetiologies: an analysis from the Global Burden of Disease Study 2017. Occup Environ Med, 2020, vol. 77, no. 6, pp. 407–414. DOI: 10.1136/oemed-2019-106321
  30. Gomzikova E.A., Samsonova M.V., Chernyaev A.L., Kurkov A.V. Pulmonary amyloidosis: basis of diagnosis. Prakticheskaya pul'monologiya, 2017, no. 3, pp. 90–97 (in Russian).
  31. Khoor A., Colby T.V. Amyloidosis of the Lung. Arch Pathol Lab Med, 2017, vol. 141, no. 2, pp. 247–254. DOI: 10.5858/arpa.2016-0102-RA
  32. Povzun A.S., Shchemeleva E.V., Povzun S.A., Safoev M.I. Problemy diagnostiki vtorichnogo amiloidoza pri revmaticheskikh zabolevaniyakh [Issues related to secondary amyloidosis diagnostics in patients with rheumatic diseases]. Skoraya meditsinskaya pomoshch', 2014, vol. 15, no. 3, pp. 47–51 (in Russian).
Received: 
06.05.2020
Accepted: 
11.11.2020
Published: 
30.12.2020

You are here

Home